UNH vs BIIB
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Biogen Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | BIIB |
|---|---|---|
| Price | $427.89 | $216.03 |
| Market cap | $388.59B | $31.89B |
| P/E ratio | 32.3 | 23.3 |
| ROE | 12.18% | 7.70% |
| Profit margin | 2.68% | 13.80% |
| Revenue growth | 2.00% | 1.90% |
| Dividend yield | 2.17% | — |
| Beta | 0.65 | 0.18 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs BIIB in plain English
- UNH is the bigger company — about 12.2× the market cap of BIIB.
- BIIB is cheaper on earnings (P/E 23.3 vs 32.3).
- UNH earns a higher return on equity (12% vs 8%).
- UNH is growing revenue faster (2% vs 2%).
- UNH pays a dividend (2.17%) while the other effectively doesn't.
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
BIIB return calculator
See what $1,000 in Biogen Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.